Read Full Article
Endo also announced Douglas S. Ingram's decision to resign as a director from the Company's Board of Directors effective November 6, 2017 due to ...
I'm pleased to welcome Dr. Mansukani to the Endo Board. We value the unique skill set he brings and look forward to his contributions as we continue to execute against the key priorities that we believe will enable us to achieve our Company's vision.
Dr. Mansukani will be an excellent addition to our Board of Directors. He possesses significant board experience and deep healthcare experience which should prove to be of great value to Endo.
I look forward to working closely with Endo's Board of Directors and leadership team. It is a challenging time for the industry and I'm eager to be a resource as they continue to reshape the organization for success. I am enthusiastic about the future of the Company and the opportunities ahead.
I would like to extend my sincere gratitude to Doug Ingram for his important contributions as a Board member over the past 18 months.
It's been a pleasure working with Endo and I'm confident in the leadership team and the strategic foundation that has been built. I look forward to continued partnership as a strategic advisor as the Company advances the development of collagenase clostridium histolyticum (CCH) for cellulite and plans for success.
On behalf of the entire Board, I would like to express our appreciation to Mr. Ingram for his guidance and highly valued contributions.